Sumitomo Pharma America, Inc.

This is a very early study to learn how the body absorbs, breaks down, and eliminates a single dose of an experimental oral drug called DSP-5336. It will involve 8 adults with advanced blood cancers (like leukemia or multiple myeloma) that have returned or stopped responding to a…